International Journal of Molecular Sciences | |
Effect of γ-Cyclodextrin Inclusion Complex on the Absorption of R-α-Lipoic Acid in Rats | |
Hinako Okamoto1  Hiroshi Fukumi1  Keiji Terao1  Takashi Hirota2  Ryota Uchida2  Suetada Nagayama2  Kosuke Iwamoto2  Atsushi Miyajima2  Naoko Ikuta3  | |
[1] CycloChem Bio Co., Ltd., KIBC654R 5-5-2 Minatojima-minamimachi Chuo-ku, Kobe 650-0047, Japan;Department of Biopharmaceutics, Faculty of Pharmaceutical Science, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-8510, Japan;Graduate School of Medicine, Kobe University, 7-5-2 Kusunoki-cho Chuo-ku, Kobe 650-0017, Japan; | |
关键词: γ-cyclodextrin; inclusion complex; R-α-lipoic acid; pharmacokinetic-profile; absorption; intraduodenal administration; rats; X-ray imaging; | |
DOI : 10.3390/ijms160510105 | |
来源: DOAJ |
【 摘 要 】
R-α-lipoic acid (RLA) is an endogenous organic acid, and works as a cofactor for mitochondrial enzymes and as a kind of antioxidant. Inclusion complexes of RLA withα-, β- or γ-cyclodextrins (CD) were prepared and orally administered as a suspension to rats. Among them, RLA/γ-CD showed the highest plasma exposure, and its area under theplasma concentration-time curve (AUC) of RLA was 2.2 times higher than that after oral administration of non-inclusion RLA. On the other hand, the AUC after oral administration of non-inclusion RLA and RLA/γ-CD to pylorus-ligated rats did not differ. However,the AUC after intraduodenal administration of RLA/γ-CD was 5.1 times higher than that ofnon-inclusion RLA, and was almost comparable to the AUC after intraduodenal administration of RLA-Na solution. Furthermore, the AUC after intraduodenal administration ofRLA/γ-CD was not affected by biliary ligation or co-administration of an amylase inhibitor.These findings demonstrated that RLA was absorbed from the small intestine effectively when orally administered as a γ-CD inclusion complex, which could be easily dissolved in the lumen of the intestine. In conclusion, γ-CD inclusion complex is an appropriate formulation for supplying RLA as a drug or nutritional supplement with respect to absorption.
【 授权许可】
Unknown